FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119084971> ?p ?o ?g. }

• W2119084971 endingPage "1387" @default.
• W2119084971 startingPage "1380" @default.
• W2119084971 abstract "Hemodialysis patients (HD) display high rates of cardiac diseases and mortality. In chronic kidney disease, vascular injury leads to coronary artery disease, heart failure, and stroke. Carotid intima-media thickness (CIMT) measurements are currently widely used in randomized controlled trials (RCTs) to study the efficacy of interventions. An RCT was designed for the assessment of the safety and effectiveness of spironolactone to inhibit the progression of CIMT in HD patients as a primary outcome. Secondary outcomes included measurements of plasma potassium.HD patients were randomly assigned to receive 50 mg spironolactone or placebo thrice weekly after dialysis. In between dialysis sessions, plasma potassium concentrations were measured every month. Ultrasonographic measurements of CIMT were done at the beginning of the study and after 2 years.Fifty-three age- and sex-adjusted patients (30 with drug and 23 with placebo) successfully completed the trial. There were no significant differences between the two groups in all profiles studied at baseline. Measurements of CIMT after 2 years showed a progression in the placebo group, whereas in the spironolactone group a significant decrease or even reversed CIMT was observed. Progression rates (mm/yr) were: common carotid, placebo: 0.06 +/- 0.07, spironolactone: 0.01 +/- 0.04; carotid bifurcation, placebo: 0.15 +/- 0.27, spironolactone: 0.0001 +/- 0.01; internal carotid, placebo: 0.10 +/- 0.12, spironolactone: -0.10 +/- 0.15. No episodes of hyperkalemia were observed, but a slight increase in plasma potassium was found in the spironolactone group.Fifty milligrams of spironolactone thrice weekly significantly reduced the progression of CIMT in HD patients." @default.
• W2119084971 created "2016-06-24" @default.
• W2119084971 creator A5004580743 @default.
• W2119084971 creator A5008897668 @default.
• W2119084971 creator A5018413838 @default.
• W2119084971 creator A5029913356 @default.
• W2119084971 creator A5039130731 @default.
• W2119084971 creator A5054100700 @default.
• W2119084971 creator A5055134789 @default.
• W2119084971 creator A5070811189 @default.
• W2119084971 creator A5089394054 @default.
• W2119084971 date "2010-08-01" @default.
• W2119084971 modified "2023-10-07" @default.
• W2119084971 title "A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients" @default.
• W2119084971 cites W1974025920 @default.
• W2119084971 cites W1978198437 @default.
• W2119084971 cites W1985121474 @default.
• W2119084971 cites W1985671734 @default.
• W2119084971 cites W1996762106 @default.
• W2119084971 cites W2000812251 @default.
• W2119084971 cites W2031187741 @default.
• W2119084971 cites W2032576629 @default.
• W2119084971 cites W2035318322 @default.
• W2119084971 cites W2041274276 @default.
• W2119084971 cites W2042663838 @default.
• W2119084971 cites W2049683553 @default.
• W2119084971 cites W2051612201 @default.
• W2119084971 cites W2054559423 @default.
• W2119084971 cites W2058331351 @default.
• W2119084971 cites W2058895413 @default.
• W2119084971 cites W2069527757 @default.
• W2119084971 cites W2072751592 @default.
• W2119084971 cites W2086158964 @default.
• W2119084971 cites W2093767567 @default.
• W2119084971 cites W2096645292 @default.
• W2119084971 cites W2098743344 @default.
• W2119084971 cites W2109546786 @default.
• W2119084971 cites W2113804878 @default.
• W2119084971 cites W2116968443 @default.
• W2119084971 cites W2123656765 @default.
• W2119084971 cites W2146255193 @default.
• W2119084971 cites W2147273166 @default.
• W2119084971 cites W2163780561 @default.
• W2119084971 cites W2168488559 @default.
• W2119084971 cites W2312400976 @default.
• W2119084971 cites W2316167515 @default.
• W2119084971 cites W2323458614 @default.
• W2119084971 doi "https://doi.org/10.2215/cjn.09421209" @default.
• W2119084971 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2924413" @default.
• W2119084971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20522535" @default.
• W2119084971 hasPublicationYear "2010" @default.
• W2119084971 type Work @default.
• W2119084971 sameAs 2119084971 @default.
• W2119084971 citedByCount "81" @default.
• W2119084971 countsByYear W21190849712012 @default.
• W2119084971 countsByYear W21190849712013 @default.
• W2119084971 countsByYear W21190849712014 @default.
• W2119084971 countsByYear W21190849712015 @default.
• W2119084971 countsByYear W21190849712016 @default.
• W2119084971 countsByYear W21190849712017 @default.
• W2119084971 countsByYear W21190849712018 @default.
• W2119084971 countsByYear W21190849712019 @default.
• W2119084971 countsByYear W21190849712020 @default.
• W2119084971 countsByYear W21190849712021 @default.
• W2119084971 countsByYear W21190849712022 @default.
• W2119084971 countsByYear W21190849712023 @default.
• W2119084971 crossrefType "journal-article" @default.
• W2119084971 hasAuthorship W2119084971A5004580743 @default.
• W2119084971 hasAuthorship W2119084971A5008897668 @default.
• W2119084971 hasAuthorship W2119084971A5018413838 @default.
• W2119084971 hasAuthorship W2119084971A5029913356 @default.
• W2119084971 hasAuthorship W2119084971A5039130731 @default.
• W2119084971 hasAuthorship W2119084971A5054100700 @default.
• W2119084971 hasAuthorship W2119084971A5055134789 @default.
• W2119084971 hasAuthorship W2119084971A5070811189 @default.
• W2119084971 hasAuthorship W2119084971A5089394054 @default.
• W2119084971 hasBestOaLocation W21190849711 @default.
• W2119084971 hasConcept C126322002 @default.
• W2119084971 hasConcept C141071460 @default.
• W2119084971 hasConcept C142724271 @default.
• W2119084971 hasConcept C164705383 @default.
• W2119084971 hasConcept C168563851 @default.
• W2119084971 hasConcept C204787440 @default.
• W2119084971 hasConcept C27081682 @default.
• W2119084971 hasConcept C2776379505 @default.
• W2119084971 hasConcept C2778063415 @default.
• W2119084971 hasConcept C2778198053 @default.
• W2119084971 hasConcept C2779339615 @default.
• W2119084971 hasConcept C2779978075 @default.
• W2119084971 hasConcept C2780243291 @default.
• W2119084971 hasConcept C2987047532 @default.
• W2119084971 hasConcept C71924100 @default.
• W2119084971 hasConceptScore W2119084971C126322002 @default.
• W2119084971 hasConceptScore W2119084971C141071460 @default.
• W2119084971 hasConceptScore W2119084971C142724271 @default.
• W2119084971 hasConceptScore W2119084971C164705383 @default.
• W2119084971 hasConceptScore W2119084971C168563851 @default.
• W2119084971 hasConceptScore W2119084971C204787440 @default.

• next